Filed: 5/14/2025ACC: 0001420506-25-001107
📋 What this filing means
SILVERARC CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 69 equity positions with a total reported market value of $489.00M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
69
Positions
$489.00M
Total AUM (reported)
60.37M
Total Shares
Allocation by class
COM$339.20M69.4%
SPONSORED ADS$43.48M8.9%
COM PAR $.01$24.52M5.0%
COM NEW$23.28M4.8%
SHS$14.77M3.0%
SPONSORED ADR$11.81M2.4%
CALL$7.31M1.5%
Portfolio Concentration
Top 3$99.93M20.4%
4–10$141.30M28.9%
11–25$138.89M28.4%
Rest$108.87M22.3%
Top 3 weight
20.4%
Top 10 weight
49.3%
Voting Authority Distribution
Total shares with voting rights: 60.37M
Sole
Full voting authority
60.37M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole69
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings69
Rows:
VERONA PHARMA PLC
SOLEShares545.87K
TypeSH
Market value$34.66M
7.09%
Sole
545.87K
Shared
0.00
None
0.00
MERUS N V
SOLEShares811.02K
TypeSH
Market value$34.14M
6.98%
Sole
811.02K
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares439.02K
TypeSH
Market value$31.14M
6.37%
Sole
439.02K
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares719.99K
TypeSH
Market value$29.15M
5.96%
Sole
719.99K
Shared
0.00
None
0.00
INSMED INC
SOLEShares321.37K
TypeSH
Market value$24.52M
5.01%
Sole
321.37K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares1.70M
TypeSH
Market value$19.61M
4.01%
Sole
1.70M
Shared
0.00
None
0.00
VERACYTE INC
SOLEShares633.83K
TypeSH
Market value$18.79M
3.84%
Sole
633.83K
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares337.61K
TypeSH
Market value$17.88M
3.66%
Sole
337.61K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares1.31M
TypeSH
Market value$16.08M
3.29%
Sole
1.31M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares1.38M
TypeSH
Market value$15.28M
3.12%
Sole
1.38M
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares411.31K
TypeSH
Market value$12.14M
2.48%
Sole
411.31K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares166.42K
TypeSH
Market value$11.89M
2.43%
Sole
166.42K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares75.75K
TypeSH
Market value$11.81M
2.41%
Sole
75.75K
Shared
0.00
None
0.00
DISC MEDICINE INC
SOLEShares236.47K
TypeSH
Market value$11.74M
2.40%
Sole
236.47K
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares2.06M
TypeSH
Market value$11.50M
2.35%
Sole
2.06M
Shared
0.00
None
0.00
89BIO INC
SOLEShares1.51M
TypeSH
Market value$10.98M
2.25%
Sole
1.51M
Shared
0.00
None
0.00
ERASCA INC
SOLEShares7.37M
TypeSH
Market value$10.09M
2.06%
Sole
7.37M
Shared
0.00
None
0.00
WAVE LIFE SCIENCES LTD
SOLEShares1.05M
TypeSH
Market value$8.49M
1.74%
Sole
1.05M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares72.58K
TypeSH
Market value$8.03M
1.64%
Sole
72.58K
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares408.85K
TypeSH
Market value$7.33M
1.50%
Sole
408.85K
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares180.60K
TypeSH
Market value$7.31M
1.50%
Sole
180.60K
Shared
0.00
None
0.00
GOSSAMER BIO INC
SOLEShares6.32M
TypeSH
Market value$6.95M
1.42%
Sole
6.32M
Shared
0.00
None
0.00
GILEAD SCIENCES INC
SOLEShares62.03K
TypeSH
Market value$6.95M
1.42%
Sole
62.03K
Shared
0.00
None
0.00
HELIX ACQUISITION CORP II
SOLEShares613.39K
TypeSH
Market value$6.93M
1.42%
Sole
613.39K
Shared
0.00
None
0.00
ELUTIA INC
SOLEShares2.67M
TypeSH
Market value$6.76M
1.38%
Sole
2.67M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VERONA PHARMA PLCSOLE | SPONSORED ADS | 545.87K | SH | $34.66M 7.09% | 545.87K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 811.02K | SH | $34.14M 6.98% | 811.02K | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 439.02K | SH | $31.14M 6.37% | 439.02K | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 719.99K | SH | $29.15M 5.96% | 719.99K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 321.37K | SH | $24.52M 5.01% | 321.37K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 1.70M | SH | $19.61M 4.01% | 1.70M | 0.00 | 0.00 |
VERACYTE INCSOLE | COM | 633.83K | SH | $18.79M 3.84% | 633.83K | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 337.61K | SH | $17.88M 3.66% | 337.61K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 1.31M | SH | $16.08M 3.29% | 1.31M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 1.38M | SH | $15.28M 3.12% | 1.38M | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 411.31K | SH | $12.14M 2.48% | 411.31K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 166.42K | SH | $11.89M 2.43% | 166.42K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 75.75K | SH | $11.81M 2.41% | 75.75K | 0.00 | 0.00 |
DISC MEDICINE INCSOLE | COM | 236.47K | SH | $11.74M 2.40% | 236.47K | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 2.06M | SH | $11.50M 2.35% | 2.06M | 0.00 | 0.00 |
89BIO INCSOLE | COM | 1.51M | SH | $10.98M 2.25% | 1.51M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 7.37M | SH | $10.09M 2.06% | 7.37M | 0.00 | 0.00 |
WAVE LIFE SCIENCES LTDSOLE | SHS | 1.05M | SH | $8.49M 1.74% | 1.05M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 72.58K | SH | $8.03M 1.64% | 72.58K | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 408.85K | SH | $7.33M 1.50% | 408.85K | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | CALL | 180.60K | SH | $7.31M 1.50% | 180.60K | 0.00 | 0.00 |
GOSSAMER BIO INCSOLE | COM | 6.32M | SH | $6.95M 1.42% | 6.32M | 0.00 | 0.00 |
GILEAD SCIENCES INCSOLE | COM | 62.03K | SH | $6.95M 1.42% | 62.03K | 0.00 | 0.00 |
HELIX ACQUISITION CORP IISOLE | CL A ORD SHS | 613.39K | SH | $6.93M 1.42% | 613.39K | 0.00 | 0.00 |
ELUTIA INCSOLE | CL A COM | 2.67M | SH | $6.76M 1.38% | 2.67M | 0.00 | 0.00 |
Page 1 of 3